Clinical trial
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally…
NCT00448838 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00448838 |
|---|---|
| Title | Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
| Official title | Pilot Study of Gemcitabine, Oxaliplatin, and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | Cetuximab, Gemcitabine Hydrochloride, Oxaliplatin |
| Enrollment | 42 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Mar 1, 2011 |
| First posted | Mar 19, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: